Background: The histologic diagnosis of atypical ductal hyperplasia (ADH) has been reported as having a high rate of malignancy, either ductal carcinoma in situ (DCIS) or invasive ductal carcinoma (IDC). We reviewed our surgical group's experience with stereotactic core-needle biopsies (SCNB), specifically looking at the follow-up of ADH.
Methods: From November 1994 through July 1997 our group performed 539 SCNB.
A retrospective chart review of 507 patients who underwent cholecystectomies over an 18 month period was performed. There were 345 female patients and 162 male patients. Of the female patients, 90 (26 percent) presented with complicated disease, which was severe in 38 (11 percent).
View Article and Find Full Text PDF